1. Herzog EL, Chai L, Krause DS. Plasticity of marrow-derived stem cells. Blood. 2003. 102:3483–3493.

2. Barry F, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004. 36:568–584.

3. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med. 2001. 226:507–520.

4. Dorshkind K. Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol. 1990. 8:111–137.

5. Charbord P. Stromal support of Hematopoiesis. Sell S, editor. Stem Cell Handbook. New Jersey: Humana Press;2004. 143–154.

6. Charbord P. Mediators involved in the control of hematopoiesis by the microenvironment. Zon L, editor. Hematopoiesis A developmental approach. New York: Oxford University Press;2001. 748–759.
7. Moore MAS. Cytokine and chemokine networks influencing stem cell proliferation, differentiation, and marrow homing. J Cell Biochem Suppl. 2002. 38:29–38.

8. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006. 107:367–372.

9. Plumas J, Chaperot L, Richard MJ, Molens JP, Bensa JC, Favrot MC. Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia. 2005. 19:1597–1604.

10. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells. 2006. 24:74–85.

11. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood. 2006. 107:1484–1490.

12. Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, Galun E, Rachmilewitz J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood. 2005. 105:4120–4126.

13. Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, Mao N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood. 2005. 105:4120–4126.

14. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y, Linheng L. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003. 425:836–841.

15. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003. 425:841–846.

16. Karanu FN, Murdoch B, Gallacher L, Wu DM, Koremoto M, Sakano S, Bhatia M. The Notch ligand Jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med. 2000. 192:1365–1372.

17. Arai F, Hira A, Ohmura M, Sato H, Matsuoka S, Takubo K, Ito K, Koh G, Suda T. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004. 118:149–161.

18. Van Den Berg DJ, Sharma AK, Bruno E, Hoffman R. Role of members of the Wnt gene family in human hematopoiesis. Blood. 1998. 92:3189–3202.

19. Yamane T, Kunisada T, Tsukamoto H, Yamazaki H, Niwa H, Takada S, Hayashi SI. Wnt signaling regulates hemopoiesis through stromal cells. J Immunol. 2001. 167:765–772.

20. Hackney JA, Charbord P, Brunk BP, Stoeckert CJ, Lemischka IR, Moore KA. A molecular profile of a hematopoietic stem cell niche. Proc Natl Acad Sci. 2002. 99:13061–13066.

21. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol. 1998. 176:57–66.

22. Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res. 2000. 9:841–848.

23. Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1
α. J Cell Physiol. 1998. 166:585–592.

24. Dormady SP, Bashayan O, Dougherty R, Zhang XM, Basch RS. Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment. J Hematother Stem Cell Res. 2001. 10:125–140.

25. Kim DH, Yoo KH, Choi KS, Choi J, Choi SY, Yang SE, Yang YS, Im HJ, Kim KH, Jung HL, Sung KW, Koo HH. Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell. Cytokine. 2005. 31:119–126.

26. Jeong JA, Ko KM, Bae S, Jeon C-J, Koh GY, Kim H. Genome-wide differential gene expression profiling of human mesenchymal stem cells. Stem Cells. 2007. 25:994–1002.
27. Griffin TJ, Gygi SP, Ideker T, Rist B, Eng J, Hood L, Aeber-sold R. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics. 2002. 1:323–333.

28. Lian Z, Wang L, Yamaga S, Bonds W, Beazer-Barclay Y, Kluger Y, Gerstein M, Newburger PE, Berliner N, Weissman SM. Genomic and proteomic analysis of the myeloid differentiation program. Blood. 2001. 98:513–524.

29. Haser SP, Kajkenova O, Lipschitz DA. The pivotal role of interleukin 6 in formation and function of hematopoietically active murine long-term bone marrow cultures. Stem Cells. 1997. 15:125–132.

30. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 2001. 12:375–391.

31. Liu CH, Hwang SM. Cytokine interactions in mesenchymal stem cells from the cord blood. Cytokine. 2005. 32:270–279.
